Symbols / LVTX
LVTX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-06 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- LAVA Therapeutics Reminds Shareholders to Tender Shares Ahead of XOMA Offer Expiration on November 12, 2025 - Quiver Quantitative Mon, 10 Nov 2025 08
- How LVTX stock performs after earnings - 2025 Short Interest & Free Long-Term Investment Growth Plans - mfd.ru Fri, 20 Feb 2026 22
- LAVA Therapeutics to Delist from Nasdaq Amid Acquisition - The Globe and Mail Fri, 14 Nov 2025 08
- LVTX - LAVA Therapeutics N.V. Latest Stock News & Market Updates - Stock Titan Fri, 28 Mar 2025 07
- LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty - Stocktwits hu, 16 Oct 2025 07
- LAVA Therapeutics Announces Successful Tender Offer with Over 87% Share Acceptance Prior to Expiration - Quiver Quantitative hu, 13 Nov 2025 08
- LAVA Therapeutics Cancels Extraordinary General Meeting to Finalize XOMA Royalty Acquisition Details - Quiver Quantitative ue, 30 Sep 2025 07
- Lava Therapeutics shares delisted from Nasdaq following completion of acquisition - Investing.com Fri, 21 Nov 2025 08
- LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223) - Stock Titan ue, 05 Mar 2024 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for LVTX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|